Stoke Therapeutics Inc (STOK)

EBITDA Margin

-751.40%

TTM · Period ending:

STOK logo

STOK EBITDA Margin

Latest reported-751.40%
STOK EBITDA Margin (0.00% → -751.40%)
High-resolution chart · PNG

STOK ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-2.7736%
-237.4614%
-1,164.3508%
-802.2652%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.